FDA Adverse Event Malfunction Summary report: N

EVOLUT FX VALVE

MDR report key: 24557049 · Received March 10, 2026

Report

Report Number
9617601-2026-01694
Event Type
Malfunction
Date Received
March 10, 2026
Date of Event
March 2, 2026
Report Date
March 18, 2026
Manufacturer
MEDTRONIC MEXICO S. DE R.L. DE CV
Product Code
NPT
UDI-DI
00763000370633
PMA / PMN Number
P130021
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

UPDATED DATA: B5. H6. ADDITIONAL CODES. H6. THE CODES PRESENT IN SECTION H6. CORRESPOND TO MULTIPLE COMPONENTS/PRODUCTS THAT COMPRISE THIS REPORTED EVENT. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

CONTINUATION OF D10: PRODUCT ID EVOLUTFX-34 (R227128); PRODUCT TYPE: 0195-HEART VALVES; IMPLANT DATE ; EXPLANT DATE. PRODUCT ID EVOLUTFX-26 (R204958); PRODUCT TYPE: 0195-HEART VALVES; IMPLANT DATE ; EXPLANT DATE. PRODUCT ID EVOLUTFX-34 (R231870); PRODUCT TYPE: 0195-HEART VALVES; IMPLANT DATE ; EXPLANT DATE. PRODUCT ID EVOLUTFX-29 (K953137); PRODUCT TYPE: 0195-HEART VALVES; IMPLANT DATE ; EXPLANT DATE. PRODUCT ID EVOLUTFX-29 (K950191); PRODUCT TYPE: 0195-HEART VALVES; IMPLANT DATE ; EXPLANT DATE. PRODUCT ID EVOLUTFX-26 (K007873); PRODUCT TYPE: 0195-HEART VALVES; IMPLANT DATE ; EXPLANT DATE SELECT PATIENT INFORMATION CANNOT BE INCLUDED IN THE REGULATORY REPORT DUE TO REGIONAL PRIVACY REGULATIONS. MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

ADDITIONAL INFORMATION WAS RECEIVED WHICH CLARIFIED THAT THESE VALVES WERE OPENED DURING THREE DIFFERENT PROCEDURES. THERE WAS DIFFICULTY OPENING THE VALVE JARS AND DAMAGE TO THE JAR LID SEALS WAS NOTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT PRIOR TO USE, THE TRANSCATHETER BIOPROSTHETIC VALVES EXHIBITED A SEAL ISSUE AND WHITE LOOSE PARTICLES WERE VISIBLE AFTER OPENING THE JAR LID. THE VALVES WERE NOT USED FOR IMPLANT AND WERE REPLACED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
623756 EVOLUT FX VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV NPT MEDTRONIC MEXICO S. DE R.L. DE CV EVOLUTFX-34 00763000370633

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown SEE H11...